Explain this page
Arphra AIPlain-English read on Bio-Techne Corporation’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Headline | |||||||||
| Market cap | — | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — | — |
| Multiples | |||||||||
| P / E | — | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
| Yields | |||||||||
| Earnings yield | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||
| Gross margin | +67.97% | +68.42% | +67.72% | +66.41% | +64.80% | +66.51% | +65.96% | +66.88% | +66.75% |
| Operating margin | +25.49% | +26.83% | +26.30% | +17.83% | +8.38% | +17.22% | +18.03% | +17.26% | +17.25% |
| EBITDA margin | +26.84% | +37.42% | +40.21% | +27.02% | +17.78% | +28.64% | +29.08% | +28.87% | +28.02% |
| EBIT margin | +17.41% | +28.28% | +30.78% | +17.38% | +8.77% | +18.42% | +19.15% | +18.42% | +19.22% |
| Pre-tax margin | +15.92% | +27.26% | +29.79% | +16.02% | +8.07% | +17.70% | +17.62% | +17.49% | +18.12% |
| Net margin | +15.08% | +24.61% | +25.10% | +14.50% | +6.02% | +15.17% | +15.61% | +14.85% | +15.39% |
| Cost structure | |||||||||
| Cost of revenue / sales | +32.03% | +31.58% | +32.28% | +33.59% | +35.20% | +32.88% | +33.49% | +34.13% | +33.92% |
| R&D intensity | +7.58% | +7.88% | +8.14% | +8.34% | +8.16% | +8.15% | +8.25% | +8.24% | +8.35% |
| SG&A intensity | +31.14% | +30.66% | +31.01% | +33.93% | +34.03% | +33.82% | +32.93% | +33.36% | +32.32% |
| Effective tax rate | +5.80% | +12.70% | +15.71% | +9.47% | +25.45% | +16.81% | +17.32% | +17.53% | +17.21% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| Return on equity (ROE) | +8.94% | +15.99% | +14.51% | +8.13% | +3.83% | +8.79% | +9.20% | +8.55% | +8.96% |
| Return on assets (ROA) | +6.20% | +11.86% | +10.81% | +6.22% | +2.87% | +6.59% | +6.80% | +6.53% | +7.02% |
| Return on capital (ROC) | +11.91% | +14.63% | +12.35% | +8.31% | +4.33% | +8.22% | +8.70% | +8.14% | +8.21% |
| Return on invested capital (ROIC) | +7.05% | +13.42% | +11.78% | +6.76% | +3.11% | +7.24% | +7.54% | +7.01% | +7.33% |
| Asset turnover | +41.14% | +48.18% | +43.08% | +42.87% | +47.68% | +43.42% | +43.57% | +43.99% | +45.61% |
| DuPont · ROE decomposition | |||||||||
| Net margin | +15.08% | +24.61% | +25.10% | +14.50% | +6.02% | +15.17% | +15.61% | +14.85% | +15.39% |
| Asset turnover (× revenue / assets) | +41.14% | +48.18% | +43.08% | +42.87% | +47.68% | +43.42% | +43.57% | +43.99% | +45.61% |
| Equity multiplier (× assets / equity) | +144.02% | +134.91% | +134.18% | +130.69% | +133.31% | +133.45% | +135.21% | +130.84% | +127.64% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Asset turnover | 0.41 | 0.48 | 0.43 | 0.43 | 0.48 | 0.43 | 0.44 | 0.44 | 0.46 |
| Fixed-asset turnover | 3.30 | 3.83 | 3.50 | 3.38 | 3.82 | — | — | — | — |
| Inventory turnover | 2.55 | 2.47 | 2.14 | 2.17 | 2.27 | — | — | — | — |
| Receivables turnover | 6.40 | 5.68 | 5.20 | 4.80 | 5.90 | — | — | — | — |
| Payables turnover | 10.15 | 10.31 | 14.29 | 10.25 | 16.96 | — | — | — | — |
| Days outstanding | |||||||||
| Days sales outstanding (DSO) | 57.00 | 64.23 | 70.15 | 76.02 | 61.91 | — | — | — | — |
| Days inventory outstanding (DIO) | 142.91 | 147.55 | 170.76 | 168.50 | 161.05 | — | — | — | — |
| Days payables outstanding (DPO) | 35.97 | 35.41 | 25.55 | 35.59 | 21.52 | — | — | — | — |
| Cash conversion cycle | 163.94 | 176.37 | 215.36 | 208.92 | 201.44 | — | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 2.51 | 1.20 | 0.89 | 1.78 | 3.92 | 1.58 | 1.55 | 1.61 | 1.60 |
| FCF / Net income | 2.19 | 1.03 | 0.76 | 1.40 | 3.50 | 1.36 | 1.28 | 1.36 | 1.34 |
| FCF margin | +33.07% | +25.36% | +19.02% | +20.37% | +21.03% | +20.67% | +20.02% | +20.14% | +20.60% |
| OCF margin | +37.83% | +29.42% | +22.38% | +25.80% | +23.58% | +24.04% | +24.13% | +23.87% | +24.59% |
| CapEx / Revenue | +4.76% | +4.06% | +3.36% | +5.42% | +2.54% | +3.83% | +3.83% | +3.79% | +3.74% |
| CapEx / D&A | 0.50 | 0.44 | 0.36 | 0.56 | 0.28 | — | — | — | — |
| Stock-based comp / Revenue | +5.26% | +3.82% | +3.45% | +3.28% | +3.35% | — | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 0.87 | 1.66 | 1.76 | 1.05 | 0.46 | 1.93 | 2.07 | 2.33 | 2.60 |
| EPS · basic | 0.91 | 1.73 | 1.81 | 1.07 | 0.47 | 1.96 | 2.09 | 2.41 | 2.66 |
| Book value / share | 9.70 | 10.36 | 12.15 | 12.87 | 12.01 | 12.94 | 13.46 | 15.12 | 15.53 |
| Tangible BV / share | 0.69 | 2.12 | 3.45 | 3.66 | 3.58 | 12.94 | 13.46 | 15.12 | 15.53 |
| Sales / share | 5.75 | 6.74 | 7.02 | 7.21 | 7.64 | 7.50 | 7.93 | 8.70 | 9.04 |
| Operating CF / share | 2.17 | 1.98 | 1.57 | 1.86 | 1.80 | 1.80 | 1.91 | 2.08 | 2.22 |
| Free cash flow / share | 1.90 | 1.71 | 1.34 | 1.47 | 1.61 | 1.55 | 1.59 | 1.75 | 1.86 |
| Dividends / share | 0.31 | 0.31 | 0.31 | 0.31 | 0.32 | 0.33 | 0.33 | 0.37 | 0.38 |
| Payout ratio | +35.34% | +18.45% | +17.63% | +29.99% | +68.65% | +28.88% | +26.92% | +28.90% | +27.43% |
| Retention ratio | +64.66% | +81.55% | +82.37% | +70.01% | +31.35% | +71.12% | +73.08% | +71.10% | +72.57% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E | 8y CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Top-line | ||||||||||
| Revenue · YoY | — | +18.75% | +2.81% | +1.97% | +5.23% | -1.03% | +4.57% | +9.32% | +5.04% | +5.69% |
| Gross profit · YoY | — | +19.54% | +1.76% | -0.01% | +2.67% | +1.60% | +3.71% | +10.84% | +4.84% | +5.45% |
| Profit | ||||||||||
| Operating income · YoY | — | +24.99% | +0.79% | -30.86% | -50.53% | +103.33% | +9.47% | +4.68% | +4.95% | +0.66% |
| EBITDA · YoY | — | +65.59% | +10.48% | -31.50% | -30.74% | +59.39% | +6.18% | +8.56% | +1.94% | +6.26% |
| Net income · YoY | — | +93.75% | +4.86% | -41.07% | -56.34% | +149.42% | +7.67% | +3.96% | +8.89% | +5.96% |
| Operating | ||||||||||
| EBIT · YoY | — | +92.87% | +11.89% | -42.43% | -46.89% | +107.88% | +8.72% | +5.17% | +9.57% | +7.00% |
| R&D · YoY | — | +23.42% | +6.14% | +4.51% | +2.93% | -1.10% | +5.89% | +9.09% | +6.51% | +6.97% |
| Per-share | ||||||||||
| EPS · diluted · YoY | — | +90.80% | +6.02% | -40.34% | -56.19% | +319.56% | +7.32% | +12.58% | +11.51% | +14.67% |
| EPS · basic · YoY | — | +90.11% | +4.62% | -40.88% | -56.07% | +316.03% | +6.95% | +15.42% | +10.06% | +14.33% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Leverage | |||||||||
| Total debt | $420.55M | $325.97M | $454.97M | $419.54M | $444.06M | $444.75M | $472.43M | $527.46M | $554.53M |
| Net debt | $221.46M | $153.4M | $274.39M | $267.75M | $281.87M | $278.35M | $294.49M | $335.77M | $351.74M |
| Net debt / EBITDA | 0.89 | 0.37 | 0.60 | 0.86 | 1.30 | 0.81 | 0.80 | 0.84 | 0.87 |
| Debt / equity | 0.27 | 0.19 | 0.23 | 0.20 | 0.23 | 0.21 | 0.22 | 0.22 | 0.22 |
| Debt / assets | +18.58% | +14.20% | +17.24% | +15.52% | +17.36% | +16.00% | +16.31% | +16.81% | +17.45% |
| Equity / assets | +69.43% | +74.12% | +74.53% | +76.51% | +75.02% | +74.93% | +73.96% | +76.43% | +78.34% |
| Coverage | |||||||||
| EBITDA / interest expense | 17.91 | 36.59 | 40.76 | 19.90 | 25.49 | 28.12 | 29.16 | 28.73 | 27.79 |
| Operating income / interest | 17.01 | 26.23 | 26.66 | 13.13 | 12.02 | 16.91 | 18.08 | 17.18 | 17.11 |
| Interest expense | $13.95M | $11.31M | $11.22M | $15.74M | $8.51M | $12.29M | $12.59M | $13.87M | $14.62M |
| Liquidity | |||||||||
| Current ratio | 3.35 | 3.44 | 4.84 | 3.87 | 3.46 | — | — | — | — |
| Quick ratio | 2.48 | 2.51 | 3.29 | 2.47 | 2.10 | — | — | — | — |
| Cash ratio | 1.31 | 0.98 | 1.41 | 0.95 | 0.92 | — | — | — | — |
| Working capital | $358.32M | $429.54M | $492.97M | $458.04M | $432.45M | — | — | — | — |
| Working capital / revenue | +38.49% | +38.85% | +43.37% | +39.52% | +35.46% | — | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).